comparemela.com

Latest Breaking News On - Ross bethell - Page 6 : comparemela.com

Curium Announces License and Development Agreement With Lantheus for AI-Based PSMA PET Software in Europe

Curium Announces License and Development Agreement With Lantheus for AI-Based PSMA PET Software in Europe
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
Paris
France-general
France
Etienne-montagut
Ross-bethell
Pierre-curie
Benoit-woessmer
Medicinal-products
Human-use
European-medicines-agency
European-phase

Curium Announces Publication of [18F]DCFPyL Versus

PARIS, July 21, 2023 (GLOBE NEWSWIRE) Curium, a world leader in nuclear medicine, announced today the publication of the results of its European,.

Paris
France-general
France
Amsterdam
Noord-holland
Netherlands
United-states
Sakir-mutevelic
Pierre-curie
Ross-bethell
Head-of-global-communications
Professor-in-nuclear-medicine

Curium Announces Publication of [18F]DCFPyL Versus [18F]Fluoromethylcholine Results From European Phase III Study (PYTHON Trial)

Curium Announces Publication of [18F]DCFPyL Versus [18F]Fluoromethylcholine Results From European Phase III Study (PYTHON Trial)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Amsterdam
Noord-holland
Netherlands
Paris
France-general
France
United-states
Sakir-mutevelic
Ross-bethell
Pierre-curie
Professor-in-nuclear-medicine
Progenics-pharmaceuticals-inc

Curium Receives Positive CHMP Opinion of PYLCLARI® for Primary Staging of Patients With High-Risk PCa Prior to Initial Curative Therapy and to Localize Recurrence of PCa in Patients With a Suspected Recurrence Based on Increasing Serum Prostate-Specific Antigen (PSA) Levels After Primary Treatment With Curative Intent

If approved for Europe, PYLCLARI® (INN: Piflufolastat (18F) formerly known as [18F]-DCFPyL) will offer prostate cancer patients access to a diagnostic imaging…

Paris
France-general
France
Toronto
Ontario
Canada
New-york
United-states
Sakir-mutevelic
Gabriel-friedman
Ross-bethell
Kevin-carmichael

Curium Receives Positive CHMP Opinion of PYLCLARI® for

If approved for Europe, PYLCLARI® (INN: Piflufolastat (18F) formerly known as [18F]-DCFPyL) will offer prostate cancer patients access to a diagnostic.

Paris
France-general
France
United-states
Pierre-curie
Sakir-mutevelic
Ross-bethell
Benoit-woessmer
Committee-for-medicinal-products-human-use
Head-of-global-communications
European-commission
Drug-administration

vimarsana © 2020. All Rights Reserved.